Karthik Srinivasan

Karthik Srinivasan is a seasoned leader in drug discovery and preclinical research, currently serving as VP at Viking Therapeutics, Inc., where responsibilities include overseeing clinical development support through safety and pharmacological insights. Srinivasan holds a consultancy role as a research advisor at the Broad Institute of MIT and Harvard, and previously held senior executive positions at Atomwise and Turning Point Therapeutics, focusing on the integration of AI/ML technologies in drug development and overseeing a range of pharmacological and toxicology disciplines. With extensive experience at Ferring Pharmaceuticals and Pfizer, Srinivasan has significantly contributed to multiple IND packages and clinical programs. Educational qualifications include a Ph.D. in Medicinal Chemistry from The University of Georgia and specialized training from prestigious institutions, including Harvard Medical School and the University of California, Berkeley.